Trial intelligence / Profile preview

Levocarnitine Supplementation in Pediatric Hemodialysis

NCT05948124Phase 1Unknown

Sponsor
Ain Shams University
Start
Aug 2023
Primary completion
Feb 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, double-blind trial in carnitine deficiency comparing L-Carnitine Group with Placebo Group (2 arms). Primary endpoints: Change in serum free carnitine level at 6 months, Change in cardiac functions at 6 months and 3 more. Status: unknown.

02

Drugs

levocarnitine
03

Conditions

carnitine deficiency

Beyond the preview

Go deeper on NCT05948124.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05948124.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call